↓ Skip to main content

BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges

Overview of attention for article published in Frontiers in oncology, March 2024
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
8 Mendeley